Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang(Chinese University of Hong Kong), Yuk Ming Dennis Lo(Chinese University of Hong Kong), Suk Hang Cheng(Chinese University of Hong Kong), Henry Lik‐Yuen Chan(Radiant Research (United States)), John Wong(Chinese University of Hong Kong), Rossa W. K. Chiu(Chinese University of Hong Kong), Stephen L. Chan(Chinese University of Hong Kong), Tony Mok(Chinese University of Hong Kong), K.C. Allen Chan(Rubicon Biotechnology (United States)), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Carol W. M. Chan(Chinese University of Hong Kong), Paul B.S. Lai(University of Hong Kong)
Cited by 755
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k